Perritt Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,202
Closed -$353K 218
2025
Q3
$353K Buy
4,202
+96
+2% +$7.91K 0.17% 124
2025
Q2
$325K Sell
4,106
-46
-1% -$3.66K 0.17% 121
2025
Q1
$373K Sell
4,152
-540
-12% -$50.4K 0.21% 105
2024
Q4
$467K Buy
4,692
+1,147
+32% +$118K 0.24% 103
2024
Q3
$403K Buy
3,545
+37
+1% +$4.4K 0.21% 115
2024
Q2
$434K Buy
3,508
+220
+7% +$28.3K 0.24% 102
2024
Q1
$434K Sell
3,288
-333
-9% -$41K 0.23% 102
2023
Q4
$395K Sell
3,621
-700
-16% -$72.7K 0.22% 107
2023
Q3
$445K Hold
4,321
0.26% 99
2023
Q2
$499K Sell
4,321
-50
-1% -$5.68K 0.27% 97
2023
Q1
$465K Hold
4,371
0.26% 94
2022
Q4
$485K Sell
4,371
-17
-0.4% -$1.74K 0.28% 92
2022
Q3
$378K Sell
4,388
-2
-0% -$179 0.24% 102
2022
Q2
$400K Hold
4,390
0.24% 110
2022
Q1
$360K Buy
4,390
+825
+23% +$65K 0.19% 124
2021
Q4
$273K Buy
3,565
+263
+8% +$20.9K 0.14% 153
2021
Q3
$248K Buy
3,302
+300
+10% +$22.8K 0.14% 159
2021
Q2
$233K Sell
3,002
-90
-3% -$6.69K 0.12% 167
2021
Q1
$227K Buy
+3,092
New +$228K 0.12% 162

Other funds holding MRK

Perritt Capital Management's MRK Position: Q4 2025 in Review

Perritt Capital Management sold out of Merck (MRK) in Q4 2025, closing a stake of 4,202 shares — an estimated $353K sold.

Perritt Capital Management first reported a position in MRK in Q1 2021 and held it in 19 quarters. The position peaked at $499K in Q2 2023. 3,654 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Perritt Capital Management reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • Perritt Capital Management sold 4,202 Merck shares in Q4 2025, an estimated $353K.
  • Perritt Capital Management first reported a position in Merck in Q1 2021 and held it in 19 quarters.
  • Perritt Capital Management's Merck position peaked at $499K in Q2 2023.
  • 3,654 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Perritt Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.